Inari Medical

Traded on the St. Petersburg Stock Exchange
Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
Inari Medical stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

Inari Medical balance sheet

Report period2018 2019 2020 2021 2022 Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

Inari Medical cash flows

Report period2018 2019 2020 2021 2022 Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

Inari Medical multipliers

Report period2018 2019 2020 2021 2022 Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Inari Medical profitability

Report period2018 2019 2020 2021 2022 Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
Inari Medical assets
Inari Medical cash flows

Inari Medical dividend policy

The company doesn't provide dividend.

Inari Medical shares

TickerNameTypeNominal valueISINPrice
NARI:USInari MedicalCommon share-US45332Y1091$38.59
Inari Medical news
05.05.2022
Inari Medical's GAAP loss for 3 months of 2022 was $3.129 million, compared to a profit of $7.469 million in the previous year. Revenue increased 51.1% to $86.752 million from $57.397 million a year earlier.
24.02.2022
Inari Medical's GAAP net income for 2021 was $9.84 million, down 28.6% from $13.789 million in the previous year. Revenue increased 98.3% to $276.984 million from $139.67 million a year earlier.
10.11.2021
Inari Medical's GAAP net income for 9M 2021 was $8.733 million, up 28.4% from $6.804 million in the previous year. Revenue increased 2.1-fold to $193.766 million from $91.059 million a year earlier.
11.08.2021
Inari Medical's GAAP net income for 6M 2021 was $11.537 million, up 37 times from $0.308 million in the previous year. Revenue increased 2.3-fold to $120.85 million from $52.345 million a year earlier.
General information
Company nameInari Medical
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address9 PARKER, SUITE 100 IRVINE CA 92618 949-923-4747
Mailing address9 PARKER, SUITE 100 IRVINE CA 92618
Websiteir.inarimedical.com
Information disclosurewww.sec.gov